Page last updated: 2024-10-23

bethanechol and Atherosclerotic Parkinsonism

bethanechol has been researched along with Atherosclerotic Parkinsonism in 2 studies

Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harbaugh, RE1
Roberts, DW1
Coombs, DW1
Saunders, RL1
Reeder, TM1
Fox, JH1
Bennett, DA1
Goetz, CG1
Penn, RD1
Savoy, S1
Clasen, R1
Wilson, RS1

Trials

2 trials available for bethanechol and Atherosclerotic Parkinsonism

ArticleYear
Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease.
    Neurosurgery, 1984, Volume: 15, Issue:4

    Topics: Aged; Alzheimer Disease; Animals; Bethanechol; Bethanechol Compounds; Catheters, Indwelling; Clinica

1984
Induction of parkinsonism by intraventricular bethanechol in a patient with Alzheimer's disease.
    Neurology, 1989, Volume: 39, Issue:9

    Topics: Aged; Alzheimer Disease; Bethanechol; Bethanechol Compounds; Clinical Trials as Topic; Female; Human

1989